Section 690.1530  Methods of Reporting XDRO Registry Information

a)         All patients identified at a reporting facility with a non-duplicative XDRO are reportable to the Registry within seven calendar days after the test result is finalized.  

b)         A reporting facility may report XDRO infections by one of the following methods:

1)         Option #1.  Electronic Reporting:  Health care facilities that have the capacity to submit laboratory data electronically may use this option.

2)         Option #2.  Manual Entry into a Website:  Facilities that do not have the capacity to submit laboratory data electronically shall submit the data through a Department-approved website.

c)         All reporting facilities are responsible for complete case finding, which means identifying all non-duplicative XDRO isolates.

(Source:  Added at 37 Ill. Reg. 12063, effective July 15, 2013)